Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Journal of Lipid Research

Volumn 51, Issue 10, 2010, Pages 3046-3054

  Feldstein, Ariel E ^a,b   Lopez, Rocio ^b   Tamimi, Tarek Abu Rajab ^b   Yerian, Lisa ^b   Chung, Yoon Mi ^a,b   Berk, Michael ^a,b   Zhang, Renliang ^a,b   McIntyre, Thomas M ^a,b   Hazen, Stanley L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chiral mass spectrometry; Mass spectrometry; Oxidized fatty acids

Indexed keywords

FATTY ACID; HYDROXYICOSATETRAENOIC ACID; HYDROXYSTEARIC ACID; LINOLEIC ACID; LIPID; OXOSTEARIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FATTY ACID OXIDATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK ASSESSMENT;

COHORT STUDIES; FATTY ACIDS, UNSATURATED; FATTY LIVER; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LINOLEIC ACID; LIPID METABOLISM; LIPIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 77956822767     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M007096     Document Type: Article

References (29)

1. Wieckowska, A., and A. E. Feldstein. 2005. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr. Opin. Pediatr. 17: 636-641.
2. Angulo, P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346: 1221-1231.
3. Browning, J. D., L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. C. Cohen, S. M. Grundy, and H. H. Hobbs. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40: 1387-1395.
4. Schwimmer, J. B., R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, and C. Behling. 2006. Prevalence of fatty liver in children and adolescents. Pediatrics. 118: 1388-1393.
5. Brunt, E. M., B. A. Neuschwander-Tetri, D. Oliver, K. R. Wehmeier, and B. R. Bacon. 2004. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum. Pathol. 35: 1070-1082.
6. Adams, L. A., J. F. Lymp, J. St Sauver, S. O. Sanderson, K. D. Lindor, A. Feldstein, and P. Angulo. 2005. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 129: 113-121. (Pubitemid 41002048)
7. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419.
8. Ekstedt, M., L. E. Franzen, U. L. Mathiesen, L. Thorelius, M. Holmqvist, G. Bodemar, and S. Kechagias. 2006. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 44: 865-873. (Pubitemid 46489550)
9. Wieckowska, A., A. J. McCullough, and A. E. Feldstein. 2007. Non-invasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology. 46: 582-589.
10. Wieckowska, A., and A. E. Feldstein. 2008. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin. Liver Dis. 28: 386-395.
11. Day, C. P. 2002. Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 16: 663-678.
12. Oliveira, C. P., L. C. da Costa Gayotto, C. Tatai, B. I. Della Bina, M. Janiszewski, E. S. Lima, D. S. Abdalla, F. P. Lopasso, F. R. Laurindo, and A. A. Laudanna. 2002. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J. Cell. Mol. Med. 6: 399-406.
13. Roskams, T., S. Q. Yang, A. Koteish, A. Durnez, R. DeVos, X. Huang, R. Achten, C. Verslype, and A. M. Diehl. 2003. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am. J. Pathol. 163: 1301-1311.
14. Videla, L. A., R. Rodrigo, J. Araya, and J. Poniachik. 2004. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 37: 1499-1507.
15. Gao, D., C. Wei, L. Chen, J. Huang, S. Yang, and A. M. Diehl. 2004. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1070-G1077.
16. Bonnefont-Rousselot, D., V. Ratziu, P. Giral, F. Charlotte, I. Beucler, and T. Poynard. 2006. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment. Pharmacol. Ther. 23: 91-98. (Pubitemid 43381171)
17. Chalasani, N., M. A. Deeg, and D. W. Crabb. 2004. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 1497-1502.
18. Horoz, M., C. Bolukbas, F. F. Bolukbas, T. Sabuncu, M. Aslan, S. Sarifakiogullari, N. Gunaydin, and O. Erel. 2005. Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol. 5: 35. (Pubitemid 41684581)
19. Zhang, R., Z. Shen, W. M. Nauseef, and S. L. Hazen. 2002. Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood. 99: 1802-1810.
20. Brunt, E. M., C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon. 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94: 2467-2474.
21. Kleiner, D. E., E. M. Brunt, M. Van Natta, C. Behling, M. J. Contos, O. W. Cummings, L. D. Ferrell, Y. C. Liu, M. S. Torbenson, A. Unalp-Arida, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41: 1313-1321. (Pubitemid 40770284)
22. Shishehbor, M. H., R. Zhang, H. Medina, M. L. Brennan, D. M. Brennan, S. G. Ellis, E. J. Topol, and S. L. Hazen. 2006. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic. Biol. Med. 41: 1678-1683.
23. DeLong, E. R., D. M. DeLong, and D. L. Clarke-Pearson. 1988. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44: 837-845.
24. Bonora, E., G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, et al. 2002. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 25: 1135-1141. (Pubitemid 41071163)
25. Clark, J. M., F. L. Brancati, and A. M. Diehl. 2002. Nonalcoholic fatty liver disease. Gastroenterology. 122: 1649-1657.
26. Jaeschke, H., G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters. 2002. Mechanisms of hepatotoxicity. Toxicol. Sci. 65: 166-176.
27. Higuchi, H., and G. J. Gores. 2003. Mechanisms of liver injury: an overview. Curr. Mol. Med. 3: 483-490.
28. Solga, S. F., A. Alkhuraishe, K. Cope, A. Tabesh, J. M. Clark, M. Torbenson, P. Schwartz, T. Magnuson, A. M. Diehl, and T. H. Risby. 2006. Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers. 11: 174-183.
29. Wieckowska, A., N. N. Zein, L. M. Yerian, A. R. Lopez, A. J. McCullough, and A. E. Feldstein. 2006. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology. 44: 27-33.